Blog

Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit attributable to owners for the quarter ended June 30, 2026, driven by healthy growth in its domestic business and innovative medicines portfolio. The company posted a net profit of Rs 2,894.79 crore, compared with Rs 2,278.63 crore in the corresponding period last year.